Implications of stock options vs granted restricted stock @ Series A, & or granted @ seed?
I'm trying to wrap my head around the implications of being offered stock options at Series A, vs getting them granted (company pays) as restricted stock, vs getting that same granted restricted stock now @ seed?
How do tax implications differ, cost if company doesn't pay for them, and or what friction exists with one or the other at time of sale?
I get the whole vesting schedule implications, so I'm mainly asking this question based on advantages vs disadvantages for negotiation purposes.
Thanks in advance for sharing your knowledge / experience.